首页> 外文OA文献 >Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors

【2h】

Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors

机译：芳香酶抑制剂治疗的绝经后乳腺癌患者体重指数与芳香化以及血浆和组织雌激素水平的关系

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Lønning Per Eystein; Haynes Benjamin P.; Dowsett Mitch;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors [J] . L?nningP.E., HaynesB.P., DowsettM. European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2014,第6期

机译：芳香化酶抑制剂治疗的绝经后乳腺癌患者体重指数与芳香化以及血浆和组织雌激素水平的关系
2. Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer|[ast]| [J] . J Geisler, N King, M Dowsett, British Journal of Cancer . 1996,第8期

机译：选择性非甾体芳香酶抑制剂阿那曲唑（Arimidex）对绝经后乳腺癌女性体内芳香化和血浆雌激素水平的影响|
3. Relationship between body mass index and preoperative treatment response to aromatase inhibitor exemestane in postmenopausal patients with primary breast cancer [J] . TakadaM., SajiS., MasudaN., The Breast : . 2012,第1期

机译：绝经后原发性乳腺癌患者体重指数与术前对芳香酶抑制剂依西美坦治疗反应的关系
4. Bone Density Changes during Adjuvant Aromatase Inhibitor Treatment in Breast Cancer Patients: Single Centre Experience [C] . World congress on medical physics and biomedical engineering;International congress of the IUPESM . 2011

机译：乳腺癌患者辅助芳香化酶抑制剂治疗期间的骨密度变化：单中心经验。
5. The Genetics of Aromatase Inhibitor-related Phenotypes in Postmenopausal Women with ER+ Breast Cancer [D] . Dudenkov, Tanda Tosia Murray. 2017

机译：ER +乳腺癌绝经后妇女芳香酶抑制剂相关表型的遗传
6. Influence of anastrozole (Arimidex) a selective non-steroidal aromatase inhibitor on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer. [O] . J. Geisler, N. King, M. Dowsett, 1996

机译：选择性非甾体芳香酶抑制剂阿那曲唑（Arimidex）对绝经后乳腺癌女性体内芳香化和血浆雌激素水平的影响。
7. Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors [O] . Lønning, Per Eystein, Haynes, Benjamin P., Dowsett, Mitch 2014

机译：芳香化酶抑制剂治疗绝经后乳腺癌患者体重指数与芳构化及血浆和组织雌激素水平的关系

Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors

著录项

引文网络

相似文献

相关主题

期刊订阅